Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) announced participation in key investor conferences in September 2022. Notably, they will feature in the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, with a fireside chat at 8:45 AM ET in New York City. Following this, they will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 1:30 PM ET. Lastly, they will engage in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on September 28, 2022, at 11:30 AM ET. Live webcasts will be available on their website.

BOSTON & LONDON, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company with a Research & Development (“R&D”) innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients, today announced that members of its management team will participate in the following investor conferences:

Event: Morgan Stanley 20th Annual Global Healthcare Conference
Date: Monday, September 12, 2022
Location: New York City, NY
Fireside Chat: 8:45 AM ET

Event: H.C. Wainwright 24th Annual Global Investment Conference
Date: Tuesday, September 13, 2022
Location: New York City, NY
Presentation: 1:30 PM ET

Event: Guggenheim Nantucket Therapeutics Conference
Date: Wednesday, September 28, 2022
Location: Nantucket, MA
Fireside Chat: 11:30 AM ET

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with an R&D innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We are led by a management team with extensive R&D experience, providing direct guidance to our program teams to rapidly advance our candidates from research through all stages of development. For more information, visit www.centessa.com, which does not form part of this release.

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com

FAQ

What investor conferences will Centessa Pharmaceuticals (CNTA) attend in September 2022?

Centessa Pharmaceuticals will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, and the Guggenheim Nantucket Therapeutics Conference on September 28, 2022.

When is Centessa Pharmaceuticals' presentation at the H.C. Wainwright Conference?

Centessa Pharmaceuticals' presentation at the H.C. Wainwright 24th Annual Global Investment Conference is scheduled for September 13, 2022, at 1:30 PM ET.

Where can I watch the webcasts of Centessa Pharmaceuticals' investor conference presentations?

The live webcasts of Centessa Pharmaceuticals' investor conference presentations will be accessible on their website under the 'Events and Publications' tab in the investor relations section.

What is the schedule for Centessa Pharmaceuticals' participation in the Morgan Stanley Conference?

At the Morgan Stanley 20th Annual Global Healthcare Conference, Centessa Pharmaceuticals will participate in a fireside chat on September 12, 2022, at 8:45 AM ET in New York City.

What is Centessa Pharmaceuticals' focus in the pharmaceutical industry?

Centessa Pharmaceuticals is focused on discovering, developing, and delivering impactful medicines, particularly in rare diseases and immuno-oncology.